Colorectal Cancer Market Size, Share & Trends Analysis Report By Therapies & Drugs(Chemo Therapy, Immuno Therapy, Radiation Therapy, Surgery), By Testing & Diagnosis(Immunochemistry, Macroscopy, Microscopy, Staging, Tumor Budding), By Procedures (Biopsy, Colostomy, Magnetic Resonance Imaging (MRI), Mammography Sigmoidoscopy), By Products (Flow Cytometry, In Situ Hybridization, Microarrays, Next-Generation Sequencing, Targeted Therapy), By Applications (Hospitals and Clinics, Other), Based On Region, And Segment Forecasts, 2022 - 2028

  • Report ID: BMRC 619 | Number of pages: 199 | Published Date: May 2022

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Colorectal Cancer Market Size, Share & Trends Analysis Report By Therapies & Drugs(Chemo Therapy, Immuno Therapy, Radiation Therapy, Surgery), By Testing & Diagnosis(Immunochemistry, Macroscopy, Microscopy, Staging, Tumor Budding), By Procedures (Biopsy, Colostomy, Magnetic Resonance Imaging (MRI), Mammography Sigmoidoscopy), By Products (Flow Cytometry, In Situ Hybridization, Microarrays, Next-Generation Sequencing, Targeted Therapy), By Applications (Hospitals and Clinics, Other), Based On Region, And Segment Forecasts, 2022 - 2028 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Colorectal Cancer Market is valued at USD 11.83 Billion in 2021 and is expected to reach USD 16.21 Billion by 2028 with a CAGR of 5.40% over the forecast period.

The Detailed Market intelligence report on the Colorectal Cancer Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Colorectal Cancer Market place for the forecast 2022– 2028.

Scope of Colorectal Cancer Market:

Rising acceptance of the western diet which is low in fiber and high in fat is predicted to power the development of colorectal cancer market over the coming period.

Colorectal cancer is cancer that begins in the rectum or colon. The rectum and the colon are parts of the big intestine, which is the digestive system of the body’s lower part. The colon absorbs nutrients and water from the food and amasses waste matter. Stool shifts into the rectum from the colon before it gets out of the body. Colorectal cancer often starts as a development dubbed as a polyp, which night form on the interior wall of the rectum or colon. Some polyps turn out to be cancer eventually. Finding and eliminating polyps can stop colorectal cancer. At the time of digestion, food shifts via the small intestine and stomach into the colon. Most colorectal cancers are adenocarcinomas. Some of the usually witnessed signs of colorectal cancer are blood in the fatigue, weight loss, stool, and uneven bowel movements. Colorectal cancer is an outcome of uncontrolled cell development that takes place in the colon, appendix, and the rectum region.

On the basis of treatment option, colorectal cancer is divided as radiation therapy, surgery, targeted therapy, and chemotherapy. Surgery stays the most effectual option for colorectal cancer. Radiation therapy lowers the odds of cancer recurrence or distribution and is effectual as adjuvant or additional therapy either after or before surgery. The section is predicted to develop swiftly over the coming period owing to increasing awareness and rising technical enhancements.

Report Analysis Details
Historical data 2018 - 2021
Forecast Period 2022 - 2028
Market Size in 2021: USD 11.83 Billion
Base year considered 2021
Forecast Period CAGR %:

5.40%

Market Size Expected in 2028: USD 16.21 Billion
Tables, Charts & Figures: 175
Pages 196
Colorectal Cancer Companies Beckman Coulter, Abbott Laboratories, Companion DX, Clinical Genomics, Epigenomics AG, EDP Biotech, Novigenix, F. Hoffmann-La Roche AG, Siemens Healthineers, Quest Diagnostics, VolitionRX, others
Segments Covered By Therapies & Drugs, Testing & Diagnosis, By Procedures, By Product, By Application
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Colorectal Cancer Market Segmentation:

By Therapies & Drugs

  • Chemo Therapy
  • Immuno Therapy
  • Radiation Therapy
  • Surgery

By Testing & Diagnosis

  • Immunochemistry
  • Macroscopy
  • Microscopy
  • Staging
  • Tumor Budding

By Procedures

  • Biopsy, Colostomy
  • Magnetic Resonance Imaging (MRI)
  • Mammography Sigmoidoscopy

By Products

  • Flow Cytometry
  • In Situ Hybridization
  • Microarrays
  • Next-Generation Sequencing
  • Targeted Therapy

By Applications

  • Hospitals and Clinics
  • Other Applications

Colorectal Cancer Market Key Players

The major players in the global colorectal cancer market are,

  • Beckman Coulter
  • Abbott Laboratories
  • Companion DX
  • Clinical Genomics
  • Epigenomics AG
  • EDP Biotech
  • Novigenix
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers
  • Quest Diagnostics
  • VolitionRX
  • others

Rising Acceptance of Western Diet Predicted To Power The Development Of Colorectal Cancer Market Over The Coming Period

Rising employment of targeted and biologics therapies will hinder the market for bladder cancer drugs. Biologic therapy employs immune system of a body to deal with cancer instead of chemical drugs which lowers the immune power of the body. Targeted therapies ban the spreading and development of colorectal cancer even in stage IV where chemical medicines are ineffective.

The colorectal cancer market is managed by regulatory bodies laid down by organizes such as American Society of Clinical Oncology (ASCO), European Medicines Agency (EMA), US Food and Administration Agency (FDA), and others. For example, FDA's suggestion for colorectal cancer drugs sector in the form of rules are cited inside the Code for Federal Regulations’ (CFR) under part 312 title number 21, that has sub-parts from A to I.

The United States is Predicted to Retain Biggest Market Share During the Coming Period

Area-wise, the US has holds the biggest share of the market regarding revenue and demand. Almost 95,520 new colon cancer cases and 39,910 new rectal cancer cases in 2017 were reported in the US on the basis of the forecast by the American Cancer Society. These forecasts show that colorectal cancer is rising its occurrence in the US, which is powering the development of the market. The Asia Pacific is also predicted to see a solid development pattern in the years to come, with India and China displaying rapid development. In 2015, Roche inked a deal in Shenzhen City with an insurance firm. The Chinese population was amongst the first few to accept Avastin for reimbursement. This is predicted to elevate access in China to colorectal cancer therapeutics.

On Special Requirement Colorectal Cancer Market Report is also available for the below Regions and Countries:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA

Key Benefits of Global Colorectal Cancer Industry Report–

  • Global Colorectal Cancer Industry report covers in-depth historical and forecasts analysis.
  • Global Colorectal Cancer Industry research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, and Regional and Country levels.
  • Global Colorectal Cancer Industry report helps to identify opportunities in the marketplace.
  • Global Colorectal Cancer Industry report covers an extensive analysis of emerging trends and the competitive landscape.

 


Frequently Asked Questions (FAQ) :
Colorectal Cancer Market is valued at USD 11.83 Billion in 2021.
Colorectal Cancer Market is expected to reach USD 16.21 Billion by 2028 with a CAGR of 5.40% over the forecast period.
Beckman Coulter, Abbott Laboratories, Companion DX, Clinical Genomics, Epigenomics AG, EDP Biotech, Novigenix, F. Hoffmann-La Roche AG, Siemens Healthineers, Quest Diagnostics, VolitionRX, others
Rising Acceptance of Western Diet Predicted To Power The Development Of Colorectal Cancer Market Over The Coming Period.



Interested in this report?

Colorectal Cancer Market | Statistics and Research Analysis 2028

report cover

Colorectal Cancer Market Size, Share & Trends Analysis Report By Therapies & Drugs(Chemo Therapy, Immuno Therapy, Radiation Therapy, Surgery), By Testing & Diagnosis(Immunochemistry, Macroscopy, Microscopy, Staging, Tumor Budding), By Procedures (Biopsy, Colostomy, Magnetic Resonance Imaging (MRI), Mammography Sigmoidoscopy), By Products (Flow Cytometry, In Situ Hybridization, Microarrays, Next-Generation Sequencing, Targeted Therapy), By Applications (Hospitals and Clinics, Other), Based On Region, And Segment Forecasts, 2022 - 2028

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?